Los Angeles, CA, United States of America

Jon Thomas Van Lew

This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Nanocav, LLC, Nantcell, Inc.. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Thomas Van Lew. Retrieved from https://idiyas.com/inventor/jon-thomas-van-lew-6ms0eibi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Jon Thomas Van Lew in Cellular Therapeutics

Introduction

Jon Thomas Van Lew is a prominent inventor based in Los Angeles, CA, recognized for his innovative contributions to cellular therapeutics. With a total of two patents to his name, Van Lew's work promises significant advancements in the field of biotechnology.

Latest Patents

Van Lew's latest innovations include two notable patents. The first patent focuses on an electroporation apparatus that actively compensates for resistance changes during cell electroporation. This apparatus consists of electrodes designed for directing fluid containing cells and cargo, coupled with a power source and a control circuit that monitors and adjusts the induced current. The invention enhances the effectiveness of electroporation by maintaining a consistent electric field, ensuring successful cargo delivery into the cells.

The second patent presents devices and methods aimed at delivering macrostructures into cells. This technology involves placing cells on a porous membrane and applying a force through a configurable actuator. The actuator generates pressure that facilitates the uptake of macrostructures into depleted cells, contributing to the development of engineered cells. The methods also enable the replacement of defective mitochondrial DNA, thus fostering the creation of cellular-based therapeutics for patient administration. Machine learning techniques are incorporated to optimize transfection parameters for better efficiency.

Career Highlights

Throughout his career, Jon Thomas Van Lew has collaborated with notable companies such as Nanocav, LLC and Nantcell, Inc. These affiliations have provided him with the opportunity to develop and refine his innovative technologies, further contributing to the field of cellular therapeutics.

Collaborations

Van Lew has worked alongside talented professionals in the industry, including Artin Mehrabi and Ting-Hsiang Sherry Wu. Their collaborative efforts have been instrumental in enhancing the development and application of innovative solutions in biotechnology.

Conclusion

Jon Thomas Van Lew’s inventions reflect his dedication to advancing medical technologies, specifically in the realm of cellular therapeutics. His patents illustrate a remarkable blend of innovation and practicality, which have the potential to revolutionize the way cellular interventions are approached in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…